Fingerprint
Dive into the research topics of 'Long-term effects of interleukin-17A inhibition with secukinumab in active ankylosing spondylitis: 3-year efficacy and safety results from an extension of the Phase 3 MEASURE 1 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically